/
/
/

Novelix Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)78.00
Volume (₹)926.00
High (₹)78.00
Upper Circuit78.76
Low (₹)71.60
Lower Circuit71.26
Prev Close75.01
52W High (₹)92.00
Price77.50
52W Low (₹)38.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)213.55 Cr
Div. Yield (%)0.00
PE Ratio58.83
Debt to Equity0.00
Price to Book1.51
Book Value17.63
EPS (TTM)1.28
Face Value10.00
ROE (%)0.68

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
NOVELIX-XTNSE
LTP
1W Low
1W High
Market cap (₹)
3057.1+118.1 (4.02%)
2917.70
3141.40
4,19,654Cr
1353.1+99.6 (7.95%)
1235
1384
45,862Cr
3828.1+73.95 (1.97%)
3663.70
3900
45,287Cr
974.55-14.95 (-1.51%)
950
1004.95
44,033Cr
393.65+15.75 (4.17%)
369.55
403.55
30,661Cr
471.5+3.05 (0.65%)
464.95
483.50
15,489Cr
69.79-2.49 (-3.44%)
67.60
74.97
10,686Cr
333-5.9 (-1.74%)
332
345
7,647Cr
515.15-1.9 (-0.37%)
498.95
535
6,437Cr
111.9+1.1 (0.99%)
106.25
115.90
564Cr
77.5+0.01 (0.01%)
71.60
80.35
214Cr

Key Highlights of Novelix Pharmaceuticals Ltd Balance Sheet

Novelix Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹9.95Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹9.95Cr, and the reserves and surplus of the company is ₹7.59Cr.

The company has its non-current liabilities with total liabilities of ₹27.16Cr as of 2025-03-31.

The current liabilities are ₹9.67Cr as of 2025-03-31. At the same time, current assets are ₹26.93Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹4.32Lakh and tangible assets of ₹18.57Lakh, provided in the Novelix Pharmaceuticals Ltd financial statements.